+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biomarker Discovery Outsourcing Services Market Size, Share & Trends Analysis Report 2026-2033

  • PDF Icon

    Report

  • 120 Pages
  • August 2026
  • Region: Global
  • Grand View Research
  • ID: 5899620
REQUEST CUSTOMIZATION
Description Jump to:
The global biomarker discovery outsourcing services market size was valued at USD 17.0 billion in 2025 and is projected to grow from USD 19.9 billion in 2026 to USD 76.3 billion by 2033, at a CAGR of 21.1% from 2026 to 2033. North America dominated the market, accounting for the largest share of 43.8% in 2025. The industry is anticipated to grow owing to the increasing adoption of precision medicine, rising pharmaceutical and biotechnology research and development expenditure, growing outsourcing of biomarker discovery activities to specialized service providers, expanding application of biomarkers in oncology and other chronic diseases, and continuous advancements in genomics, proteomics, metabolomics, and multi-omics technologies.

The industry is anticipated to grow owing to the increasing adoption of precision medicine, rising pharmaceutical and biotechnology research and development expenditure, growing outsourcing of biomarker discovery activities to specialized service providers, expanding application of biomarkers in oncology and other chronic diseases, and continuous advancements in genomics, proteomics, metabolomics, and multi-omics technologies. The increasing complexity of biomarker identification and validation workflows, combined with the need for advanced analytical platforms and bioinformatics expertise, is encouraging drug developers to collaborate with specialized outsourcing partners that offer integrated discovery, validation, and data analysis capabilities across multiple therapeutic areas.

The increasing adoption of precision medicine remains a primary driver of market growth. Biomarkers play a critical role in patient stratification, target identification, treatment selection, and monitoring therapeutic response, making them an essential component of modern drug development. The growing number of targeted therapies and companion diagnostics entering clinical development is increasing the demand for advanced biomarker discovery services. The requirement for genomic sequencing, transcriptomics, proteomics, and bioinformatics analysis has further increased outsourcing among pharmaceutical and biotechnology companies seeking specialized scientific expertise and access to advanced laboratory technologies without expanding internal research infrastructure.

The growing outsourcing of biomarker discovery activities is another important factor supporting market expansion. Biomarker discovery requires access to sophisticated analytical instruments, high-quality biological samples, experienced scientific personnel, and advanced computational capabilities, which involve considerable investment and operational complexity. Therefore, pharmaceutical and biotechnology companies are increasingly partnering with contract research organizations and specialized biomarker service providers to improve development efficiency and accelerate clinical programs. This trend is further supported by continuous investments in advanced biomarker platforms. For instance, in July 2026, CellCarta launched its Global Digital Pathology and AI Consortium to integrate digital pathology, artificial intelligence, and spatial biology capabilities for biomarker discovery, patient stratification, and companion diagnostic development, further strengthening its outsourced biomarker discovery service offerings for precision medicine programs.

Market growth is moderated by the high cost of advanced omics technologies, challenges associated with biomarker validation and regulatory acceptance, and concerns related to biological sample quality and data standardization. The increasing adoption of artificial intelligence-driven biomarker discovery platforms, the expansion of multi-omics research, and the rising investment in precision oncology and personalized therapeutics are expected to create substantial opportunities for biomarker discovery outsourcing service providers over the coming years.

Thus, the biomarker discovery outsourcing services market is expected to witness steady growth as pharmaceutical and biotechnology companies continue to expand precision medicine research, increase outsourcing of specialized discovery activities, and invest in advanced biomarker-driven drug development programs. The continued evolution of multi-omics technologies, bioinformatics, and translational research capabilities is expected to further strengthen demand for integrated biomarker discovery outsourcing services.

Global Biomarker Discovery Outsourcing Services Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global biomarker discovery outsourcing services market report based on biomarker type, therapeutic area, discovery phase, end-use, and region:

Biomarker Type Outlook (Revenue, USD Billion, 2021 - 2033)

  • Predictive Biomarkers
  • Prognostic Biomarkers
  • Safety Biomarkers
  • Surrogate Endpoints

Therapeutic Area Outlook (Revenue, USD Billion, 2021 - 2033)

  • Oncology
  • Neurology
  • Cardiology
  • Autoimmune Diseases
  • Other Therapeutic Area

Discovery Phase Outlook (Revenue, USD Billion, 2021 - 2033)

  • Biomarker Identification
  • Biomarker Validation
  • Biomarker Profiling
  • Biomarker Panel Development
  • Biomarker Selection

End-use Outlook (Revenue, USD Billion, 2021 - 2033)

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Other End Use

Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • UAE
  • Saudi Arabia
  • Kuwait
  • Qatar
  • Oman

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Biomarker Type
1.2.2. Therapeutic Area
1.2.3. Discovery Phase
1.2.4. End Use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. The internal database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Top-Down Analysis
1.7.3. Bottom-Up Approach
1.7.4. Multivariate Analysis
1.8. List Of Secondary Sources
1.9. List Of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Biomarker Discovery Outsourcing Services Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing Demand for Biomarkers in Drug Development
3.2.1.2. Expanding R&D Investment in Biopharmaceuticals
3.2.1.3. Rising Prevalence of Chronic and Infectious Diseases
3.2.1.4. Increasing focus on personalized medicine and targeted therapies
3.2.1.5. Advancements in Omics Technologies
3.2.1.6. Increasing Role of CROs and CDMOs Owing to Cost and Time Efficiency
3.2.2. Market Restraint Analysis
3.2.2.1. Limited Reproducibility & Validation Challenges
3.2.2.2. High Cost of Biomarker Discovery & Validation
3.2.2.3. Data Privacy & Security Concerns
3.3. Technology Landscape
3.3.1. Integration of AI and Big Data in Biomarker Research
3.3.2. Omics Technologies
3.3.3. Role of Bioinformatics & Cloud Computing
3.4. Pricing Model Analysis
3.5. Value Chain Analysis
3.6. Market Analysis Tools
3.6.1. Porter’s Five Force Analysis
3.6.2. PESTEL Analysis
Chapter 4. Biomarker Discovery Outsourcing Services Market: Biomarker Type Estimates & Trend Analysis
4.1. Biomarker Discovery Outsourcing Services Market, Biomarker Type: Segment Dashboard
4.2. Biomarker Discovery Outsourcing Services Market, Biomarker Type: Movement Analysis
4.3. Biomarker Discovery Outsourcing Services Market Estimates & Forecasts, Biomarker Type, 2021 - 2033 (USD Billion)
4.4. Predictive Biomarkers
4.4.1. Predictive Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
4.5. Prognostic Biomarkers
4.5.1. Prognostic Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
4.6. Safety Biomarkers
4.6.1. Safety Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
4.7. Surrogate Endpoints
4.7.1. Surrogate Endpoints Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Chapter 5. Biomarker Discovery Outsourcing Services Market: Therapeutic Area Estimates & Trend Analysis
5.1. Biomarker Discovery Outsourcing Services Market, Therapeutic Area: Segment Dashboard
5.2. Biomarker Discovery Outsourcing Services Market, Therapeutic Area: Movement Analysis
5.3. Biomarker Discovery Outsourcing Services Market Estimates & Forecasts, Therapeutic Area, 2021 - 2033 (USD Billion)
5.4. Oncology
5.4.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
5.5. Neurology
5.5.1. Neurology Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
5.6. Cardiology
5.6.1. Cardiology Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
5.7. Autoimmune Diseases
5.7.1. Autoimmune Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
5.8. Other Therapeutic Area
5.8.1. Other Therapeutic Area Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Chapter 6. Biomarker Discovery Outsourcing Services Market: Discovery Phase Estimates & Trend Analysis
6.1. Biomarker Discovery Outsourcing Services Market, Discovery Phase: Segment Dashboard
6.2. Biomarker Discovery Outsourcing Services Market, Discovery Phase: Movement Analysis
6.3. Biomarker Discovery Outsourcing Services Market Estimates & Forecasts, Discovery Phase, 2021 - 2033 (USD Billion)
6.4. Biomarker Identification
6.4.1. Biomarker Identification Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
6.5. Biomarker Validation
6.5.1. Biomarker Validation Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
6.6. Biomarker Profiling
6.6.1. Biomarker Profiling Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
6.7. Biomarker Panel Development
6.7.1. Biomarker Panel Development Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
6.8. Biomarker Selection
6.8.1. Biomarker Selection Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Chapter 7. Biomarker Discovery Outsourcing Services Market: End Use Estimates & Trend Analysis
7.1. Biomarker Discovery Outsourcing Services Market, End Use: Segment Dashboard
7.2. Biomarker Discovery Outsourcing Services Market, End Use: Movement Analysis
7.3. Biomarker Discovery Outsourcing Services Market Estimates & Forecasts, End Use, 2021 - 2033 (USD Billion)
7.4. Pharmaceutical Companies
7.4.1. Pharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.5. Biotechnology Companies
7.5.1. Biotechnology Companies Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.6. Others
7.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Chapter 8. Biomarker Discovery Outsourcing Services Market: Regional Estimates & Trend Analysis
8.1. Regional Market Dashboard
8.2. Regional Market Share Analysis, 2025 & 2033
8.3. North America
8.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.3.2. U.S
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Framework
8.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.3.3. Canada
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.3.4. Mexico
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Framework
8.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.4. Europe
8.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.4.2. UK
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.4.3. Germany
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.4.4. France
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.4.5. Italy
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Framework
8.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.4.6. Spain
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Framework
8.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.4.7. Denmark
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Framework
8.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.4.8. Sweden
8.4.8.1. Key Country Dynamics
8.4.8.2. Competitive Scenario
8.4.8.3. Regulatory Framework
8.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.4.9. Norway
8.4.9.1. Key Country Dynamics
8.4.9.2. Competitive Scenario
8.4.9.3. Regulatory Framework
8.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.5. Asia Pacific
8.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.5.2. Japan
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.5.3. China
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.5.4. India
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.5.5. Australia
8.5.5.1. Key Country Dynamics
8.5.5.2. Competitive Scenario
8.5.5.3. Regulatory Framework
8.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.5.6. Thailand
8.5.6.1. Key Country Dynamics
8.5.6.2. Competitive Scenario
8.5.6.3. Regulatory Framework
8.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.5.7. South Korea
8.5.7.1. Key Country Dynamics
8.5.7.2. Competitive Scenario
8.5.7.3. Regulatory Framework
8.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.6. Latin America
8.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.6.2. Brazil
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.6.3. Argentina
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.7. MEA
8.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.7.2. South Africa
8.7.2.1. Key Country Dynamics
8.7.2.2. Competitive Scenario
8.7.2.3. Regulatory Framework
8.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.7.3. UAE
8.7.3.1. Key Country Dynamics
8.7.3.2. Competitive Scenario
8.7.3.3. Regulatory Framework
8.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.7.4. Saudi Arabia
8.7.4.1. Key Country Dynamics
8.7.4.2. Competitive Scenario
8.7.4.3. Regulatory Framework
8.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.7.5. Kuwait
8.7.5.1. Key Country Dynamics
8.7.5.2. Competitive Scenario
8.7.5.3. Regulatory Framework
8.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.7.6. Qatar
8.7.6.1. Key Country Dynamics
8.7.6.2. Competitive Scenario
8.7.6.3. Regulatory Framework
8.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.7.7. Oman
8.7.7.1. Key Country Dynamics
8.7.7.2. Competitive Scenario
8.7.7.3. Regulatory Framework
8.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Chapter 9. Competitive Landscape
9.1. Key Participant Categorization
9.1.1. Market Leaders
9.1.2. Emerging Players
9.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
9.3. Company Profiles
9.3.1. Laboratory Corporation of America Holdings (LabCorp)
9.3.1.1. Company Overview
9.3.1.2. Financial Performance
9.3.1.3. Service Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Charles River Laboratories
9.3.2.1. Company Overview
9.3.2.2. Financial Performance
9.3.2.3. Service Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Eurofins Scientific
9.3.3.1. Company Overview
9.3.3.2. Financial Performance
9.3.3.3. Service Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Celerion
9.3.4.1. Company Overview
9.3.4.2. Financial Performance
9.3.4.3. Service Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. ICON plc.
9.3.5.1. Company Overview
9.3.5.2. Financial Performance
9.3.5.3. Service Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Parexel International (MA) Corporation
9.3.6.1. Company Overview
9.3.6.2. Financial Performance
9.3.6.3. Service Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Proteome Sciences
9.3.7.1. Company Overview
9.3.7.2. Financial Performance
9.3.7.3. Service Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. GHO Capital
9.3.8.1. Company Overview
9.3.8.2. Financial Performance
9.3.8.3. Service Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Thermo Fisher Scientific Inc.
9.3.9.1. Company Overview
9.3.9.2. Financial Performance
9.3.9.3. Service Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. Evotec
9.3.10.1. Company Overview
9.3.10.2. Financial Performance
9.3.10.3. Service Benchmarking
9.3.10.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Biomarker Discovery Outsourcing Services Market, Region, 2021 - 2033 (USD Billion)
Table 4 Global Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 5 Global Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 6 Global Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 7 Global Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
Table 8 North America Biomarker Discovery Outsourcing Services Market, Country, 2021 - 2033 (USD Billion)
Table 9 North America Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 10 North America Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 11 North America Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 12 North America Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
Table 13 U.S Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 14 U.S Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 15 U.S Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 16 U.S Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
Table 17 Canada Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 18 Canada Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 19 Canada Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 20 Canada Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
Table 21 Mexico Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 22 Mexico Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 23 Mexico Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 24 Mexico Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
Table 25 Europe Biomarker Discovery Outsourcing Services Market, Country, 2021 - 2033 (USD Billion)
Table 26 Europe Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 27 Europe Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 28 Europe Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 29 Europe Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
Table 30 Germany Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 31 Germany Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 32 Germany Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 33 Germany Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
Table 34 UK Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 35 UK Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 36 UK Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 37 UK Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
Table 38 France Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 39 France Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 40 France Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 41 France Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
Table 42 Italy Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 43 Italy Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 44 Italy Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 45 Italy Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
Table 46 Spain Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 47 Spain Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 48 Spain Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 49 Spain Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
Table 50 Denmark Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 51 Denmark Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 52 Denmark Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 53 Denmark Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
Table 54 Sweden Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 55 Sweden Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 56 Sweden Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 57 Sweden Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
Table 58 Norway Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 59 Norway Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 60 Norway Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 61 Norway Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
Table 62 Asia Pacific Biomarker Discovery Outsourcing Services Market, Country, 2021 - 2033 (USD Billion)
Table 63 Asia Pacific Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 64 Asia Pacific Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 65 Asia Pacific Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 66 Asia Pacific Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
Table 67 China Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 68 China Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 69 China Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 70 China Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
Table 71 Japan Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 72 Japan Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 73 Japan Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 74 Japan Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
Table 75 India Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 76 India Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 77 India Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 78 India Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
Table 79 South Korea Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 80 South Korea Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 81 South Korea Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 82 South Korea Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
Table 83 Australia Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 84 Australia Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 85 Australia Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 86 Australia Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
Table 87 Thailand Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 88 Thailand Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 89 Thailand Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 90 Thailand Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
Table 91 Latin America Biomarker Discovery Outsourcing Services Market, Country, 2021 - 2033 (USD Billion)
Table 92 Latin America Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 93 Latin America Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 94 Latin America Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 95 Latin America Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
Table 96 Brazil Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 97 Brazil Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 98 Brazil Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 99 Brazil Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
Table 100 Argentina Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 101 Argentina Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 102 Argentina Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 103 Argentina Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
Table 104 Middle East & Africa Biomarker Discovery Outsourcing Services Market, Country, 2021 - 2033 (USD Billion)
Table 105 Middle East & Africa Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 106 Middle East & Africa Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 107 Middle East & Africa Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 108 Middle East & Africa Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
Table 109 South Africa Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 110 South Africa Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 111 South Africa Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 112 South Africa Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
Table 113 Saudi Arabia Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 114 Saudi Arabia Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 115 Saudi Arabia Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 116 Saudi Arabia Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
Table 117 UAE Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 118 UAE Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 119 UAE Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 120 UAE Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
Table 121 Kuwait Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 122 Kuwait Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 123 Kuwait Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 124 Kuwait Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
Table 125 Oman Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 126 Oman Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 127 Oman Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 128 Oman Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
Table 129 Qatar Biomarker Discovery Outsourcing Services Market, Biomarker Type, 2021 - 2033 (USD Billion)
Table 130 Qatar Biomarker Discovery Outsourcing Services Market, Therapeutic Area, 2021 - 2033 (USD Billion)
Table 131 Qatar Biomarker Discovery Outsourcing Services Market, Discovery Phase, 2021 - 2033 (USD Billion)
Table 132 Qatar Biomarker Discovery Outsourcing Services Market, End Use, 2021 - 2033 (USD Billion)
List of Figures
Fig. 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Market formulation & validation
Figure 6 Commodity flow analysis
Figure 7 Value-chain-based sizing & forecasting
Figure 8 QFD model sizing & forecasting
Figure 9 Bottom-up approach
Figure 10 Market snapshot
Figure 11 Segment snapshot 1
Figure 12 Segment snapshot 2
Figure 13 Competitive landscape snapshot
Figure 14 Parent market outlook, 2025 (USD Billion)
Figure 15 Ancillary market outlook, 2025 (USD Billion)
Figure 16 Biomarker Discovery Outsourcing Services Market Dynamics
Figure 17 Porter’s five forces analysis
Figure 18 PESTEL analysis
Figure 19 Biomarker Discovery Outsourcing Services Market: Biomarker Type outlook and key takeaways
Figure 20 Biomarker Discovery Outsourcing Services Market: Biomarker Type movement analysis
Figure 21 Predictive Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 22 Prognostic Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 23 Safety Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 24 Surrogate Endpoints Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 25 Biomarker Discovery Outsourcing Services Market: Therapeutic Area outlook and key takeaways
Figure 26 Biomarker Discovery Outsourcing Services Market: Therapeutic Area movement analysis
Figure 27 Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 28 Neurology Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 29 Cardiology Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 30 Autoimmune Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 31 Other Therapeutic Area Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 32 Biomarker Discovery Outsourcing Services Market: Discovery Phase outlook and key takeaways
Figure 33 Biomarker Discovery Outsourcing Services Market: Discovery Phase movement analysis
Figure 34 Biomarker Identification Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 35 Biomarker Validation Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 36 Biomarker Profiling Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 37 Biomarker Panel Development Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 38 Biomarker Selection Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 39 Biomarker Discovery Outsourcing Services Market: End Use outlook and key takeaways
Figure 40 Biomarker Discovery Outsourcing Services Market: End Use movement analysis
Figure 41 Pharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 42 Biotechnology Companies Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 43 Other End Use Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 44 Regional Marketplace: Key Takeaways
Figure 45 North America Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 46 U.S. Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 47 Canada Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 48 Mexico Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 49 Europe Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 50 UK Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 51 Germany Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 52 France Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 53 Italy Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 54 Spain Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 55 Sweden Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 56 Denmark Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 57 Norway Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 58 Asia Pacific Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 59 Japan Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 60 China Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 61 India Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 62 Thailand Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 63 South Korea Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 64 Australia Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 65 Latin America Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 66 Brazil Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 67 Argentina Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 68 Middle East & Africa Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 69 South Africa Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 70 Saudi Arabia Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 71 UAE Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 72 Kuwait Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 73 Oman Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Figure 74 Qatar Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Companies Mentioned

  • LabCorp
  • Charles River Laboratories International, Inc.
  • Eurofins Scientific
  • Celerion
  • ICON plc
  • Parexel International (MA) Corporation
  • Proteome Sciences
  • GHO Capital
  • Thermo Fisher Scientific Inc.
  • Evotec

Related Topics

Related Reports

Biomarker Discovery Outsourcing Services Market Report 2026 - Product Image

Biomarker Discovery Outsourcing Services Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Biomarker Discovery Outsourcing Services - Global Strategic Business Report 2026 - Product Image

Biomarker Discovery Outsourcing Services - Global Strategic Business Report 2026

  • Report
  • 216 Pages
  • Global
From
Biomarker Discovery Outsourcing Services Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035 - Product Image

Biomarker Discovery Outsourcing Services Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035

  • Report
  • 140 Pages
  • Global
From
Biomarker Discovery Services Market - Strategic Insights and Forecasts (2026-2035) - Product Image

Biomarker Discovery Services Market - Strategic Insights and Forecasts (2026-2035)

  • Report
  • 180 Pages
  • Global
From
AI In Biomarker Discovery - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

AI In Biomarker Discovery - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 140 Pages
  • Global
From

About the Biomarker Discovery Market

Biomarker Discovery is a field of research that focuses on the identification and characterization of biomarkers, which are biological molecules that can be used to measure and monitor the progression of a disease or condition. Biomarkers can be used to diagnose, predict, and monitor the effectiveness of treatments. They can also be used to identify individuals at risk of developing a disease or condition. Biomarker Discovery is a rapidly growing field, with many companies investing in research and development. Companies such as Illumina, Qiagen, and Thermo Fisher Scientific are leading the way in developing new technologies and products for biomarker discovery. Other companies such as Roche, Abbott, and Agilent Technologies are also investing in biomarker discovery, offering a range of products and services. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.